BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//EBAN - ECPv5.5.0.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:EBAN
X-ORIGINAL-URL:https://www.eban.ieempresas.com
X-WR-CALDESC:Events for EBAN
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20190701T000000
DTEND;TZID=UTC:20190701T000000
DTSTAMP:20260612T230050
CREATED:20190621T000000Z
LAST-MODIFIED:20200318T131756Z
UID:26171-1561939200-1561939200@www.eban.ieempresas.com
SUMMARY:Investing in Biotechnology Startups - Case of Anti-inflammatory Treatments
DESCRIPTION:Join EBAN’s latest Health Webinar on Investing in Biotechnology Startups\, led by Edward Vali\, General Partner at Accelerate Venture Partners on July 1st at 14:00 CEST. The Webinar will focus on how health sciences are becoming more democratized and decentralized\, hacking biotechnology investments is getting more accessible\, obvious\, and transparent. Investing in biotech is no longer reserved for specialized VCs and funds with deep pockets. This one hour webinar will discuss finding the right opportunities in responsible healthcare investing\, focusing on investing in biotech companies. \nRegister Here \n\n\n\n\n\nSpeaker: Edward Vali \nGeneral Partner at Accelerate Venture Partners \nEdward Vali is general partner at Accelerate Venture Partners\, the investment and advisory arm of private family office with primary focus on transformative technologies\, including applications of AI\, blockchain\, tokenized business models\, and innovations in life sciences. Edward has been a contributor to the European Commission’s PRISM project on Intellectual Capital\, particularly for healthtech companies in venture-backed investments.
URL:https://www.eban.ieempresas.com/event/investing-in-biotechnology-startups-case-of-anti-inflammatory-treatments/
CATEGORIES:Events
END:VEVENT
END:VCALENDAR